AAAAAA
Results: 1-25/62
Authors:
LIPPONEN P
AALTOMAA S
ESKELINEN M
ALAOPAS M
KOSMA VM
Citation: P. Lipponen et al., EXPRESSION OF P21(WAF1 CIP1) PROTEIN IN TRANSITIONAL-CELL BLADDER-TUMORS AND ITS PROGNOSTIC VALUE/, European urology, 34(3), 1998, pp. 237-243
Authors:
MAKINEN K
HAKALA T
LIPPONEN P
ALHAVA E
ESKELINEN M
Citation: K. Makinen et al., CLINICAL CONTRIBUTION OF BCL-2, P53 AND KI-67 PROTEINS IN PANCREATIC DUCTAL ADENOCARCINOMA, Anticancer research, 18(1B), 1998, pp. 615-618
Authors:
SETALA L
KOSMA VM
LIPPONEN P
NAUKKARINEN A
NORDLING S
HOLLMEN S
ESKELINEN M
SYRJANEN K
ALHAVA E
Citation: L. Setala et al., CLINICAL RELEVANCE OF P53 INDEX AND EXPRESSION OF PROLIFERATING CELL NUCLEAR ANTIGEN AND KI-67 IN GASTRIC-CANCER, Journal of cancer research and clinical oncology, 124(9), 1998, pp. 497-502
Authors:
LIPPONEN P
AALTOMA S
KOSMA VM
ALAOPAS M
ESKELINEN M
Citation: P. Lipponen et al., EXPRESSION OF CD44 STANDARD AND VARIANT-V6 PROTEINS IN TRANSITIONAL-CELL BLADDER-TUMORS AND THEIR RELATION TO PROGNOSIS DURING A LONG-TERM FOLLOW-UP, Journal of pathology, 186(2), 1998, pp. 157-164
Authors:
ROPPONEN K
TAMMI M
PARKKINEN J
ESKELINEN M
TAMMI R
LIPPONEN P
AGREN U
ALHAVA E
KOSMA VM
Citation: K. Ropponen et al., TUMOR CELL-ASSOCIATED HYALURONAN AS AN UNFAVORABLE PROGNOSTIC FACTOR IN COLORECTAL-CANCER, Cancer research, 58(2), 1998, pp. 342-347
Authors:
SUONIO E
LIPPONEN P
MAENPAA J
SYRJANEN K
KANGAS L
TUOMISTO L
Citation: E. Suonio et al., MITOTIC INDEX IN THE SUBRENAL CAPSULE ASSAY AS AN INDICATOR OF THE CHEMOSENSITIVITY OF OVARIAN-CANCER, Cancer chemotherapy and pharmacology, 41(1), 1997, pp. 15-21
Authors:
AALTOMAA S
LIPPONEN P
VESALAINEN S
ALAOPAS M
ESKELINEN M
SYRJANEN K
Citation: S. Aaltomaa et al., VALUE OF KI-67 IMMUNOLABELING AS A PROGNOSTIC FACTOR IN PROSTATE-CANCER, European urology, 32(4), 1997, pp. 410-415
Authors:
AALTOMAA S
LIPPONEN P
ALAOPAS M
ESKELINEN M
SYRJANEN K
Citation: S. Aaltomaa et al., PROGNOSTIC VALUE OF KI-67 EXPRESSION IN RENAL-CELL CARCINOMAS, European urology, 31(3), 1997, pp. 350-355
Authors:
LIPPONEN P
VESALAINEN S
Citation: P. Lipponen et S. Vesalainen, EXPRESSION OF THE APOPTOSIS SUPPRESSING PROTEIN BCL-2 IN PROSTATIC ADENOCARCINOMA IS RELATED TO TUMOR MALIGNANCY, The Prostate, 32(1), 1997, pp. 9-15
Authors:
PIRINEN R
LIPPONEN P
AALTOMAA S
SYRJANEN K
Citation: R. Pirinen et al., PROGNOSTIC VALUE OF EPIDERMAL GROWTH-FACTOR EXPRESSION IN BREAST-CANCER, Journal of cancer research and clinical oncology, 123(1), 1997, pp. 63-68
Authors:
KOSMA VM
ROPPONEN K
PARKKINEN JJ
LIPPONEN P
AGREN U
TAMMI R
TAMMI M
ALHAVA E
ESKELINEN M
Citation: Vm. Kosma et al., EXPRESSION OF HYALURONAN AND SURVIVAL IN COLORECTAL-CANCER, Laboratory investigation, 76(1), 1997, pp. 325-325
Authors:
SETALA L
LIPPONEN P
KOSMA VM
MARIN S
ESKELINEN M
SYRJANEN K
ALHAVA E
Citation: L. Setala et al., NUCLEAR MORPHOMETRY AS A PREDICTOR OF DISEASE OUTCOME IN GASTRIC-CANCER, Journal of pathology, 181(1), 1997, pp. 46-50
Authors:
IKAHEIMO R
SIITONEN A
HEISKANEN T
KARKKAINEN U
KUOSMANEN P
LIPPONEN P
MAKELA PH
Citation: R. Ikaheimo et al., RECURRENCE OF URINARY-TRACT INFECTION IN A PRIMARY-CARE SETTING - ANALYSIS OF A 1-YEAR FOLLOW-UP OF 179 WOMEN, Clinical infectious diseases, 22(1), 1996, pp. 91-99
Authors:
ROPPONEN K
ESKELINEN M
KOSMA VM
LIPPONEN P
PAAKKINEN P
ALHAVA E
Citation: K. Ropponen et al., COMPARISON OF CLASSIC AND QUANTITATIVE PROGNOSTIC FACTORS IN COLORECTAL-CANCER, Anticancer research, 16(6B), 1996, pp. 3875-3882
Authors:
LIPPONEN P
VESALAINEN S
KASURINEN J
ALAOPAS M
SYRJANEN K
Citation: P. Lipponen et al., A PROGNOSTIC SCORE FOR PROSTATIC ADENOCARCINOMA BASED ON CLINICAL, HISTOLOGICAL, BIOCHEMICAL AND CYTOMETRIC DATA FROM THE PRIMARY TUMOR, Anticancer research, 16(4A), 1996, pp. 2095-2100
Authors:
PIETILAINEN T
LIPPONEN P
AALTOMAA S
ESKELINEN M
KOSMA VM
SYRJANEN K
Citation: T. Pietilainen et al., THE IMPORTANT PROGNOSTIC VALUE OF KI-67 EXPRESSION AS DETERMINED BY IMAGE-ANALYSIS IN BREAST-CANCER, Journal of cancer research and clinical oncology, 122(11), 1996, pp. 687-692
Authors:
TOROPAINEN E
LIPPONEN P
SYRJANEN K
Citation: E. Toropainen et al., EXPRESSION OF INSULIN-LIKE GROWTH-FACTOR-I (IGF-I) IN FEMALE BREAST-CANCER AS RELATED TO ESTABLISHED PROGNOSTIC FACTORS AND LONG-TERM PROGNOSIS, European journal of cancer, 31A(9), 1995, pp. 1443-1448
Authors:
AUVINEN P
LIPPONEN P
JOHANSSON R
SYRJANEN K
Citation: P. Auvinen et al., PROGNOSTIC-SIGNIFICANCE OF TGF-BETA-2 EXPRESSION IN FEMALE BREAST-CANCER, European journal of cancer, 31A(5), 1995, pp. 851-851
Authors:
PIETILAINEN T
LIPPONEN P
AALTOMAA S
ESKELINEN M
KOSMA VM
SYRJANEN K
Citation: T. Pietilainen et al., EXPRESSION OF RETINOBLASTOMA GENE PROTEIN (RB) IN BREAST-CANCER AS RELATED TO ESTABLISHED PROGNOSTIC FACTORS AND SURVIVAL, European journal of cancer, 31A(3), 1995, pp. 329-333
Authors:
VESALAINEN S
LIPPONEN P
TALJA M
SYRJANEN K
Citation: S. Vesalainen et al., BIOCHEMICAL PARAMETERS AS PROGNOSTIC FACTORS IN PROSTATIC ADENOCARCINOMA, Acta oncologica, 34(1), 1995, pp. 53-59
Authors:
VESALAINEN S
LIPPONEN P
TALJA M
KASURINEN J
SYRJANEN K
Citation: S. Vesalainen et al., NUCLEAR MORPHOMETRY IS OF INDEPENDENT PROGNOSTIC VALUE ONLY IN TI PROSTATIC ADENOCARCINOMAS, The Prostate, 27(2), 1995, pp. 110-117
Authors:
VESALAINEN S
LIPPONEN P
TALJA M
SYRJANEN K
Citation: S. Vesalainen et al., MITOTIC-ACTIVITY AND PROGNOSIS IN PROSTATIC ADENOCARCINOMA, The Prostate, 26(2), 1995, pp. 80-86
Authors:
AUVINEN P
LIPPONEN P
JOHANSSON R
SYRJANEN K
Citation: P. Auvinen et al., PROGNOSTIC-SIGNIFICANCE OF TGF-BETA-1 AND TGF-BETA-2 EXPRESSIONS IN FEMALE BREAST-CANCER, Anticancer research, 15(6B), 1995, pp. 2627-2631
Authors:
PIRINEN R
LIPPONEN P
SYRJANEN K
Citation: R. Pirinen et al., EXPRESSION OF EPIDERMAL GROWTH-FACTOR RECEPTOR (EGFR) IN BREAST-CANCER AS RELATED TO CLINICAL, PROGNOSTIC AND CYTOMETRIC FACTORS, Anticancer research, 15(6B), 1995, pp. 2835-2840
Authors:
ESKELINEN M
LIPPONEN P
NORDLING S
Citation: M. Eskelinen et al., PROGNOSTIC EVALUATION OF DNA FLOW-CYTOMETRY AND HISTOMORPHOLOGICAL CRITERIA IN RENAL-CELL CARCINOMA, Anticancer research, 15(5), 1995, pp. 2279-2283